Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

October 01, 1999; Volume 56,Issue 4

Articles

  • You have access
    The Hemoregulatory Peptide pEEDCK May Inhibit Stem Cell Proliferation via Hydropathic Binding to Antisense Sequence Motifs in Interleukin-11 and Other Growth Factors
    Johanna B. Paukovits, Rosalia Rutter, Erika Ganglberger, Heidi I. Karlic, Brigitte Marian and Walter R. Paukovits
    Molecular Pharmacology October 1999, 56 (4) 665-674;
  • You have access
    Regulation of D1 Dopamine Receptors with Mutations of Protein Kinase Phosphorylation Sites: Attenuation of the Rate of Agonist-Induced Desensitization
    Dong Jiang and David R. Sibley
    Molecular Pharmacology October 1999, 56 (4) 675-683;
  • You have access
    Regulation of G Protein Activation and Effector Modulation by Fusion Proteins between the Human 5-Hydroxytryptamine1AReceptor and the α Subunit of Gi1α: Differences in Receptor-Constitutive Activity Imparted by Single Amino Acid Substitutions in Gi1α
    Elaine Kellett, I. Craig Carr and Graeme Milligan
    Molecular Pharmacology October 1999, 56 (4) 684-692;
  • You have access
    Characterization of the Activation Pathway of Phosphoramidate Triester Prodrugs of Stavudine and Zidovudine
    Didier Saboulard, Lieve Naesens, Dominique Cahard, Antonio Salgado, Ranjith Pathirana, Sonsoles Velazquez, Christopher McGuigan, Erik De Clercq and Jan Balzarini
    Molecular Pharmacology October 1999, 56 (4) 693-704;
  • You have access
    Characterization of Human A2B Adenosine Receptors: Radioligand Binding, Western Blotting, and Coupling to Gqin Human Embryonic Kidney 293 Cells and HMC-1 Mast Cells
    Joel Linden, Tami Thai, Heidi Figler, Xiaowei Jin and Anna S. Robeva
    Molecular Pharmacology October 1999, 56 (4) 705-713;
  • You have access
    Mechanisms and Interaction of Vinblastine and Reduced Glutathione Transport in Membrane Vesicles by the Rabbit Multidrug Resistance Protein Mrp2 Expressed in Insect Cells
    Rémon A. M. H. Van Aubel, Jan B. Koenderink, Janny G. P. Peters, Carel H. Van Os and Frans G. M. Russel
    Molecular Pharmacology October 1999, 56 (4) 714-719;
  • You have access
    Properties of the Novel ATP-Gated Ionotropic Receptor Composed of the P2X1 and P2X5 Isoforms
    William R. Haines, Gonzalo E. Torres, Mark M. Voigt and Terrance M. Egan
    Molecular Pharmacology October 1999, 56 (4) 720-727;
  • You have access
    A Dileucine-Based Motif in the C-Terminal Tail of the Lutropin/Choriogonadotropin Receptor Inhibits Endocytosis of the Agonist-Receptor Complex
    Kazuto Nakamura and Mario Ascoli
    Molecular Pharmacology October 1999, 56 (4) 728-736;
  • You have access
    Elevated Extracellular K+ Concentrations InhibitN-Methyl-d-Aspartate-Induced Ca2+ Influx and Excitotoxicity
    Lech Kiedrowski
    Molecular Pharmacology October 1999, 56 (4) 737-743;
  • You have access
    Protection against Nitric Oxide-Induced Apoptosis in Rat Mesangial Cells Demands Mitogen-Activated Protein Kinases and Reduced Glutathione
    Katrin B. Sandau, Dagmar Callsen and Bernhard Brüne
    Molecular Pharmacology October 1999, 56 (4) 744-751;
  • You have access
    Differential Modulation of the γ-Aminobutyric Acid Type C Receptor by Neuroactive Steroids
    Kendall D. W. Morris, Charles N. Moorefield and Jahanshah Amin
    Molecular Pharmacology October 1999, 56 (4) 752-759;
  • You have access
    Inhibition of Aryl Hydrocarbon-Induced Cytochrome P-450 1A1 Enzyme Activity and CYP1A1 Expression by Resveratrol
    Henry P. Ciolino and Grace Chao Yeh
    Molecular Pharmacology October 1999, 56 (4) 760-767;
  • You have access
    Mutagenesis of the Rat α1 Subunit of the γ-Aminobutyric AcidA Receptor Reveals the Importance of Residue 101 in Determining the Allosteric Effects of Benzodiazepine Site Ligands
    Susan M. J. Dunn, Martin Davies, Anna Lisa Muntoni and Jeremy J. Lambert
    Molecular Pharmacology October 1999, 56 (4) 768-774;
  • You have access
    Differential Modulation of Agonist Potency and Receptor Coupling by Mutations of Ser388Tyr and Thr389Pro at the Junction of Transmembrane Domain VI and the Third Extracellular Loop of Human M1 Muscarinic Acetylcholine Receptors
    Xi-Ping Huang, Frederick E. Williams, Steven M. Peseckis and William S. Messer
    Molecular Pharmacology October 1999, 56 (4) 775-783;
  • You have access
    Resveratrol Has Antagonist Activity on the Aryl Hydrocarbon Receptor: Implications for Prevention of Dioxin Toxicity
    Robert F. Casper, Monique Quesne, Ian M. Rogers, Takuhiko Shirota, André Jolivet, Edwin Milgrom and Jean-François Savouret
    Molecular Pharmacology October 1999, 56 (4) 784-790;
  • You have access
    The Importance of a Nitrogen Atom in Modulators of Multidrug Resistance
    G. Ecker, M. Huber, D. Schmid and P. Chiba
    Molecular Pharmacology October 1999, 56 (4) 791-796;
  • You have access
    Dissociated Glucocorticoids with Anti-Inflammatory Potential Repress Interleukin-6 Gene Expression by a Nuclear Factor-κB-Dependent Mechanism
    Wim Vanden Berghe, Elisa Francesconi, Karolien De Bosscher, Michèle Resche-Rigon and Guy Haegeman
    Molecular Pharmacology October 1999, 56 (4) 797-806;
  • You have access
    Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation
    Don E. Griswold, Stephen A. Douglas, Lenox D. Martin, T. Gregg Davis, Laura Davis, Zhaohui Ao, Mark A. Luttmann, Mark Pullen, Ponnal Nambi, Douglas W. P. Hay and Eliot H. Ohlstein
    Molecular Pharmacology October 1999, 56 (4) 807-812;
  • You have access
    Cross Talk Between m3-Muscarinic and β2-Adrenergic Receptors at the Level of Receptor Phosphorylation and Desensitization
    David C. Budd, R. A. John Challiss, Kenneth W. Young and Andrew B. Tobin
    Molecular Pharmacology October 1999, 56 (4) 813-823;
  • You have access
    Requirement of Intracellular Calcium Mobilization for Peroxynitrite-Induced Poly(ADP-Ribose) Synthetase Activation and Cytotoxicity
    László Virág, Gwen S. Scott, Péter Antal-Szalmás, Michael O’Connor, Hiroshi Ohshima and Csaba Szabó
    Molecular Pharmacology October 1999, 56 (4) 824-833;
  • You have access
    The Difference between the CB1 and CB2Cannabinoid Receptors at Position 5.46 Is Crucial for the Selectivity of WIN55212-2 for CB2
    Z. H. Song, Carole-Anne Slowey, Dow P. Hurst and Patricia H. Reggio
    Molecular Pharmacology October 1999, 56 (4) 834-840;
  • You have access
    Human RNase H-Mediated RNA Cleavage from DNA-RNA Duplexes Is Inhibited by 6-Deoxythioguanosine Incorporation into DNA
    Natalia F. Krynetskaia, Eugene Y. Krynetski and William E. Evans
    Molecular Pharmacology October 1999, 56 (4) 841-848;

Erratum

  • You have access
    Correction for vol. 56, p. 272
    Molecular Pharmacology October 1999, 56 (4) 849;
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 56 (4)
Molecular Pharmacology
Vol. 56, Issue 4
1 Oct 1999
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics